Press Release | 11.14.17 Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Press Release | 10.16.17 Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy
Press Release | 09.20.17 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
Press Release | 06.22.17 The Parker Institute for Cancer Immunotherapy Trains the Next Generation of Scientific Leaders in Cancer Immunotherapy
Press Release | 06.19.17 Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
Press Release | 06.01.17 Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors, Novel CAR-Ts and the Microbiome’s Potential in Immunotherapy
Press Release | 03.28.17 Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research
Press Release | 12.01.16 Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
Press Release | 07.13.16 UCLA study unlocks key mechanisms that determine acquired resistance to immunotherapy in advanced melanoma
Press Release | 06.15.16 Parker Institute for Cancer Immunotherapy Adds Key Leader to Drive Clinical Research Efforts